OIP — The Opportunity Intelligence PlatformMy OIPOIP / Government Intelligence
Preparing the stored Government Intelligence discovery view.
OIP / Government Intelligence / Opportunity detail
Source: Stored live-derived Government dataNational Institutes of Health
OIP derived this review page from stored live-derived Government Intelligence source records. The official source and issuing agency remain authoritative.
Opportunity Intelligence Platform is an independent service and is not affiliated with or endorsed by the U.S. Government. Official notices, amendments, attachments, eligibility requirements, funding terms, and deadlines remain under source control.
OIP scores and explanations are informational and do not guarantee eligibility, suitability, compliance, contract award, or financial outcome.
No funding amount is disclosed in the stored source fields.
Others (see text field entitled "Additional Information on Eligibility" for clarification)
2 warning(s) require review.
Objective score, derived by OIP · How it works
Publication decision: Publish with warning
Emerging Global Leader Award (K43 Independent Clinical Trial Required) -- a Grant (Grant) issued by National Institutes of Health.
Objective Government score 66 for grants-gov-356724, computed from source evidence and Government scoring configuration.
potential_value (not_applicable): potential_value is structurally not applicable for this Government category. difficulty (insufficient_evidence): difficulty could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate. time_required (insufficient_evidence): time_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate. capital_required (insufficient_evidence): capital_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate. novelty (insufficient_evidence): novelty could not be scored: no current Government source provides a reliable per-record signal for whether an opportunity is genuinely novel versus long-standing.
12 evidence record(s) support this pipeline result.
Next action: Review the official Grants.gov opportunity and follow the listed application package instructions.
86/100 · Ok
evidence_quality reflects a federal-source baseline plus completeness of deadline, funding value, eligibility, and official-source fields on this specific record.
75/100 · Ok
confidence reflects OIP's confidence in its own interpretation of this record's lifecycle and funding-value status, not confidence that any applicant will qualify.
No numeric value · Not Applicable
potential_value is structurally not applicable for this Government category.
62/100 · Ok
urgency reflects the number of days remaining until the disclosed application deadline.
No numeric value · Insufficient Evidence
difficulty could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
No numeric value · Insufficient Evidence
time_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
No numeric value · Insufficient Evidence
capital_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
$.detail.opportunityTitle · Field Mapping · 98/100 confidence
356724 / PAR-24-295
$.detail.id · Field Mapping · 99/100 confidence
National Institutes of Health
$.detail.synopsis.agencyName · Field Mapping · 97/100 confidence
Grant
$.detail.synopsis.fundingInstruments · Field Mapping · 96/100 confidence
This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.
$.detail.synopsis.synopsisDesc · Field Mapping · 94/100 confidence
2024-10-15T04:00:00.000Z
$.detail.synopsis.postingDate · Field Mapping · 96/100 confidence
2026-12-03T00:00:00.000Z
$.searchHit.closeDate · Field Mapping · 92/100 confidence
Applicant types: Others (see text field entitled "Additional Information on Eligibility" for clarification)
$.detail.synopsis.applicantTypes · Field Mapping · 94/100 confidence
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). FIC's Country Eligibility Notice (NOT-TW-12-011 Notice of Change in Country Eligibility for Fogarty International Training Grants ) applies to this NOFO and states that for competing and re-competing research training grant applications (including the K43 mechanism), with the exception of Sub-Saharan African countries, FIC will no longer accept applications from, or applications that involve training of scientists from upper-middle-income countries that are also members of the G20 major economies (http://www.g20.org/en/members). For additional information see FIC's Country Eligibility page at https://www.fic.nih.gov/Grants/Pages/country-eligibility.aspx. Only non-domestic (non-U.S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Official source materials control eligibility, deadlines, amendments, attachments, and funding terms.
Open official source60/100 · Ok
risk reflects the number of material evidence gaps on this record (undisclosed value, missing deadline, unlisted eligibility, or a stale source date), not ordinary competitive uncertainty.
No numeric value · Insufficient Evidence
novelty could not be scored: no current Government source provides a reliable per-record signal for whether an opportunity is genuinely novel versus long-standing.
$.detail.synopsis.applicantEligibilityDesc · Field Mapping · 94/100 confidence
value_not_disclosed
$.detail.synopsis · Field Mapping · 84/100 confidence
2024-10-15T17:59:46.000Z
$.detail.synopsis.lastUpdatedDate · Field Mapping · 88/100 confidence
PAR-24-295-Full-Announcement.html
$.detail.synopsisAttachmentFolders[0].synopsisAttachments[0] · Field Mapping · 90/100 confidence